A New Way: Alleviating Postembolization Syndrome Following Transcatheter Arterial Chemoembolization

作者：Feng Yinglu; Ling Changquan^*; Zhai Xiaofeng; Li Bai; Zhu Dezeng; Chen Zhe

来源：Journal of Alternative and Complementary Medicine, 2009, 15(2): 175-181.

DOI：10.1089/acm.2008.0093

Background: Currently, most therapies of postembolization syndrome following transcatheter arterial chemoembolization (TACE) aim directly at a single symptom, thus leading to limitations.
Objectives: To seek for a systematic approach to prevent and treat the syndrome, we carried out this study to observe the effect of ginsenosides (GS) and dexamethasone (Dex) in alleviating the postembolization syndrome following TACE.
Methods: In the randomized, double-blinded and controlled trial, 120 patients with primary liver cancer were divided into 4 groups, with 30 patients in each group. The changes of clinical symptoms and laboratory tests before TACE and on 3 and 7 days after TACE were observed.
Results: The results indicated that Dex combined with GS not only markedly decreased the occurrence ratio and duration of such symptoms as nausea, vomiting, and fever, but also significantly reduced levels of total bilirubin, glutamic oxaloacetic transaminase, and glutamic-pyruvic transaminase (AST) and improved the Child-Pugh stage of liver function as compared with single use of GS or Dex.
Conclusions: In conclusion, although single use of Dex or GS may improve some indices of adverse effects after TACE, the combination of Dex and GS can systematically prevent and treat the postembolization syndrome following TACE.

• 出版日期2009-2
• 单位中国人民解放军第二军医大学